Sudden unexpected death in young athletes: reconsidering "hypertrophic cardiomyopathy"

Thomas Rowland1

  • 1Department of Pediatrics, Baystate Medical Center, Springfield, MA 01199, USA. thomas.rowland@bhs.org

Pediatrics
|April 2, 2009
PubMed

Insights

Sudden cardiac death in young athletes may not always be hypertrophic cardiomyopathy. Exaggerated athletic training may cause extreme hypertrophy, leading to electrical instability and cardiac events.

Area of Science:

  • Sports Cardiology
  • Cardiovascular Pathology
  • Exercise Physiology

Background:

  • Sudden unexpected cardiac death (SUCD) in young athletes is often attributed to hypertrophic cardiomyopathy (HCM).
  • Observed demographic features in some SUCD cases are inconsistent with typical HCM diagnoses.
  • These inconsistencies suggest alternative explanations for cardiac events in elite athletes.

Purpose of the Study:

  • To critically review the evidence linking ventricular hypertrophy in athletes to sudden cardiac death.
  • To propose an alternative hypothesis for SUCD in athletes with extreme myocardial hypertrophy.
  • To explore the concept of electrical stability in athletes with training-induced cardiac remodeling.

Main Methods:

  • Literature review of studies on sudden cardiac death in athletes.
  • Analysis of demographic data and autopsy findings in young athletes.
  • Examination of physiological responses to intense sports training on cardiac structure.

Main Results:

  • Certain demographic patterns in SUCD cases do not align with classic HCM.
  • A common feature across these cases is significant ventricular hypertrophy.
  • This hypertrophy may be an adaptive response to extreme training, potentially leading to electrical instability.

Conclusions:

  • The diagnosis of hypertrophic cardiomyopathy may be overemphasized in certain athlete SUCD cases.
  • Extreme, training-induced myocardial hypertrophy could be a distinct entity predisposing to cardiac events.
  • Further research is needed to differentiate between pathological HCM and physiological hypertrophy in athletes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...